Schedule 13G ownership disclosure
Orchestra BioMed Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 68572M106
Event date: 2025-11-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tasso Partners, LLC
Shares: 2,849,592.00 · Class: 5.0%
- Dana Lorenzo
Shares: 3,098,592.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-114092
- Form type
- SCHEDULE 13G
- Filer
- Orchestra BioMed Holdings, Inc.
- CIK
- CIK 1814114
- Filed
- Nov 19, 2025
- Reporting period
- Nov 15, 2025
- Description
- Schedule 13G beneficial ownership